Study guide
Systemic Therapy Patient Education and Home Safety
OCN Oncology Certified Nurse Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: OCN Exam Orientation and Official Source Control
Official Sources and Credential Purpose Eligibility, Application, and Fees Exam Format, Scoring, Blueprint, and Generic Drugs PSI Scheduling, ATT, Test Day, and Results Blueprint-Based Study Plan and Readiness
2 Chapter 2: Care Continuum, Prevention, Survivorship, and End-of-Life Care
Health Promotion, Risk Reduction, and Epidemiology Screening, Early Detection, and High-Risk Referrals Navigation, Coordination, and Care Continuity Palliative Care, Advance Care Planning, and Goals Survivorship, Rehabilitation, Recurrence, and Late Effects Sexuality, Family Support, Discrimination, and Social Needs End-of-Life Care, Hospice, Bereavement, and Comfort Measures
3 Chapter 3: Oncology Science and Site-Specific Cancer Assessment
Carcinogenesis, Immunology, and Cancer Biology Genomic, Genetic Testing, and Biomarker Literacy Clinical Trials, Research Protocols, and Informed Participation Diagnostic Workup, Biopsy, Imaging, and Pathology Basics Staging, Grading, Prognosis, and Performance Status Common Cancer Patterns and Metastatic Sites Oncology Assessment, Data Clustering, and Escalation
4 Chapter 4: Professional Oncology Nursing Practice, Safety, and Standards
Scope, Standards, Nursing Process, and Documentation Collaboration, Communication, and Interprofessional Practice Safe Handling, PPE, Occupational Health, and Exposure Response Culturally Congruent Care, Advocacy, and Ethics Self-Care, Compassion Fatigue, Burnout, and Professional Development
5 Chapter 5: Treatment Modalities I - Surgery, Radiation, Transplant, Localized and Oral Therapy
Surgery and Procedural Oncology Nursing Care Radiation Therapy Principles, Toxicities, and Teaching Blood and Marrow Transplant Foundations Localized Therapy: Intrathecal, Intravesical, and Regional Care Oral Oncology Therapy Adherence, Safety, and Education Treatment Sequencing, Response Monitoring, and Care Coordination Modality-Specific Patient Teaching and Documentation
6 Chapter 6: Treatment Modalities II - Systemic Therapy, Immunotherapy, and Targeted Agents
Chemotherapy Foundations and Infusion Safety Biotherapy, Immunotherapy, and Immune-Related Adverse Events Targeted Therapy, Immune Cell, and Bispecific Antibody Basics Hormonal Therapy and Endocrine Cancer Treatment Considerations Vascular Access, Infusion Monitoring, and Extravasation Prevention Systemic Therapy Patient Education and Home Safety Therapy Response, Adherence, and Toxicity Escalation
7 Chapter 7: Symptom Management and Supportive Care
Symptom Assessment, Toxicity Grading, and Prioritization Hematologic, Immunologic, and Infection Supportive Care GI, GU, Nutrition, and Hydration Supportive Care Integumentary, Ostomy, Lymphedema, and Wound Care Respiratory, Cardiovascular, Neurologic, and Musculoskeletal Symptoms Pain Management, Pharmacologic, and Integrative Care Vascular Access Device Care and Supportive Care Coordination
8 Chapter 8: Oncologic Emergencies and Rapid Escalation
Sepsis, SIRS, Neutropenic Infection, and Shock Tumor Lysis, Hypercalcemia, SIADH, and Metabolic Emergencies Hypersensitivity, Anaphylaxis, and Infusion Reactions Spinal Cord Compression, SVC Syndrome, Increased ICP, and Obstructions DIC, VTE, Bleeding, and Thrombotic Emergencies Pneumonitis, Extravasation, and Local Therapy Emergencies Immune-Related Emergencies, CRS, ICANS, and Urgent Triage
9 Chapter 9: Psychosocial Dimensions of Oncology Care
Distress Screening, Emotional Response, and Crisis Care Cultural, Spiritual, Religious, and Language-Responsive Care Family, Caregiver Support, and Shared Decision-Making Sexuality, Fertility, Gender, and Body Image Concerns Learning Barriers, Health Literacy, and Patient Education Financial Toxicity, Support Systems, and Resource Referrals
10 Chapter 10: Mixed OCN Case Labs
New Diagnosis Navigation and Treatment Planning Case Lab Chemotherapy Infusion Reaction and Extravasation Case Lab Immunotherapy Toxicities and CRS ICANS Case Lab Radiation Surgery and Localized Therapy Case Lab Symptom Management Neutropenia Pain and Nutrition Case Lab Oncologic Emergency TLS SVC Cord Compression Case Lab Survivorship Palliative Psychosocial and Discharge Case Lab
11 Chapter 11: Final Review, High-Yield Tables, and OCN Exam-Day Readiness
Blueprint Quick Reference and Domain Triage High-Yield Oncology Safety and Emergency Tables Generic Drug Stems, Labs, and Supportive Care Patterns Final Week Practice Plan, Error Log, and Stamina Final 48 Hours, PSI Test Day, and Retake Planning
Systemic Therapy Patient Education and Home Safety
Key Takeaways Explain This Topic AI
Teach-back is the standard to confirm understanding; open-ended demonstration beats yes/no questions and handouts alone.
Body fluids remain hazardous about 48 hours after IV chemotherapy; teach double-flushing toilets and separate laundry handling.
Oral anticancer agents are hazardous drugs requiring original containers, no crushing unless instructed, gloves for caregivers, and refill planning before the bottle empties.
Neutropenic fever (single temperature 38.3C / 101F or higher, or 38.0C / 100.4F or higher sustained one hour) is the most important urgent-call threshold to teach.
Every patient leaves with a 24/7 oncology contact pathway and a treatment card naming immunotherapy, CAR T-cell, bispecific, or oral chemotherapy.
Last updated: October 2026
Systemic Therapy Patient Education and Home Safety
Education is a safety intervention, not a discharge form. Patients must know the regimen, why it is given, how it is administered, expected side effects, and which symptoms require immediate contact. Tailor teaching to literacy, language, culture, caregiver availability, transportation, and finances. Teach-back (asking the patient to explain in their own words) is the standard because information is delivered during stressful visits.
Urgent-Call Thresholds
The single most important threshold is neutropenic fever . A widely taught trigger is a single oral temperature of 38.3C (101F) or higher, or a sustained 38.0C (100.4F) or higher, for one hour, especially when the absolute neutrophil count may be low. Patients must understand fever can be the only sign of life-threatening infection because neutropenia blunts the usual signs.
- Call urgently for Why it matters
- Fever >=38.3C / 101F (or >=38.0C / 100.4F x1h) Possible neutropenic sepsis, an oncology emergency
- Chest pain or severe dyspnea Reaction, embolism, cardiac event, or pneumonitis
- Uncontrolled vomiting or diarrhea Dehydration, electrolyte loss, renal injury, colitis
- Bleeding, black stool, new bruising Thrombocytopenia or GI bleeding
- Confusion, seizure, new weakness, severe headache Neurotoxicity, stroke, metabolic emergency
- Home Hazardous-Drug Safety
Body fluids stay hazardous for roughly 48 hours after IV chemotherapy. Teach patients to flush the toilet twice with the lid down , wash hands, and launder soiled linens separately. Caregivers wear gloves when handling body fluids or pills. Oral anticancer agents are hazardous drugs: keep in original child-resistant containers, store away from children and pets, never crush or split unless instructed, and do not place unused drug in household trash unless directed.
Oral Therapy Adherence and Daily Living
Review the exact schedule, food requirements, what to do if vomiting follows a dose, and missed-dose direction from the label or team, never improvised . Ask about swallowing difficulty, cost, insurance delays, shipment timing, cognition, and caregiver support; begin refill planning before the bottle is nearly empty. For infection prevention, teach hand hygiene, food safety, oral and skin care, and avoiding sick contacts. For bleeding precautions, teach a soft toothbrush, avoiding injury, and checking before NSAIDs.
Emergency Planning
Every patient leaves with a 24/7 contact pathway and a treatment card listing diagnosis, regimen, allergies, central-line details, and the oncology number. In the emergency department, the patient should state they are on cancer treatment and name immunotherapy, CAR T-cell therapy, bispecific antibodies, or oral chemotherapy, because outside clinicians may not recognize the associated risks. Confirm the patient has a thermometer, phone access, and transportation before relying on the plan.
Tailoring and Confirming Education
Education should end with action, not information overload. After teaching, ask the patient to show where the emergency number is stored, state the temperature and symptoms that would make them call, and explain how they will obtain refills. If the patient cannot answer, the plan needs reinforcement or simplification rather than another handout. Check for the practical determinants of safety, a working thermometer, transportation, phone access, caregiver backup, and a secure place to store hazardous medication, because these details often decide whether teaching works once the patient leaves the clinic.
Caregiver education should respect patient consent while preparing the home team to recognize emergencies and reduce exposure.
Infection and Bleeding Precautions in Depth
Infection prevention is the highest-stakes home topic during myelosuppression. Teach meticulous hand hygiene, avoidance of crowds and sick contacts during the expected nadir (often 7-14 days after a dose for many regimens), safe food handling, daily oral care with a soft brush, and prompt fever reporting. Patients should ask before dental procedures, live vaccinations, or new medications because immune status and timing matter.
Bleeding precautions during thrombocytopenia include avoiding injury, using a soft toothbrush, shaving with an electric razor, reporting blood in urine or stool or new bruising, and checking before any NSAID or supplement that affects clotting. Activity should balance fatigue against safe movement, and patients should report falls because of bleeding risk.
Anchoring Teaching to the Specific Regimen
Generic handouts fail because patients cannot apply them. Start every teaching session with the regimen name and the generic drug names, then explain the route, schedule, visit length, monitoring plan, and supportive medications without offering independent dosing changes. Walk through the expected effects for this regimen, fatigue, nausea, diarrhea, mucositis, neuropathy, infection and bleeding risk, fertility and sexual-health changes, so the patient can recognize what is normal, then sharply separate those from the urgent symptoms that should bypass routine messaging.
The contrast is the point: a patient who knows that hair thinning is expected but a fever of 101F is an emergency will triage their own symptoms correctly at 2 a.m. Document the teaching delivered, the barriers identified, and the patient's teach-back response, because that record is what the next clinician and the quality team rely on.
Practical Barriers Decide Whether Teaching Works
The best instructions fail without the means to act on them. Before discharge, the nurse confirms the patient owns a working thermometer and knows how to read it, has reliable phone access and the after-hours number stored, has transportation to the emergency department, and has a backup caregiver if they live alone. For oral hazardous agents, confirm a secure storage location away from children and pets and a refill plan that starts before the bottle empties, accounting for specialty-pharmacy shipment delays that can leave a patient without medication for days.
These logistics, not clinical knowledge alone, frequently determine whether a patient survives a neutropenic fever at home.